Sunday, 28 April 2024
Anacor Pharmaceuticals Inc.
18:03 | 30/9/17
The Ledger Gazette
Receive News & Ratings for Anacor Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anacor Pharmaceuticals Inc and related companies with MarketBeat.com's FREE ...
more»
01:07 | 4/9/17
The Ledger Gazette
Receive News & Ratings for Anacor Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anacor Pharmaceuticals Inc and related companies with MarketBeat.com's FREE ...
more»
02:15 | 10/8/17
Medgadget (blog)
HTF Market Intelligence released a new research report of 56 pages on title 'Contact Dermatitis - Pipeline Review, H1 2017' with detailed analysis, forecast and strategies.
more»
00:56 | 27/7/17
WeeklyHub
Among 5 analysts covering Anacor Pharmaceuticals Inc. (NASDAQ:ANAC), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive.
more»
01:07 | 23/4/17
The Cerbat Gem
Receive News & Stock Ratings for Anacor Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anacor Pharmaceuticals Inc and related stocks with our FREE daily email ...
more»
13:57 | 24/1/17
Wall Street Beacon
Wall Street is predicting that Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC)'s earnings per share (EPS) will be $N/A when the firm is expected to announce earnings around N/A.
more»
14:02 | 20/1/17
Wall Street Beacon
Wall Street analysts covering Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) shares are predicting that the stock will trade between $N/A and $N/A within the next year.
more»
07:05 | 17/1/17
Wall Street Beacon
Wall Street is predicting that Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC)'s earnings per share (EPS) will be $N/A when the firm is expected to announce earnings around N/A.
more»
13:13 | 12/1/17
Markets Daily
It establishes stock sentiment by reviewing news published on different wired channels on a firm. They contemplate on the most impactful sources at regular intervals.
more»
08:11 | 4/1/17
Engelwood Daily
Wall Street is predicting that Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC)'s earnings per share (EPS) will be $N/A when the firm is expected to announce earnings around N/A.
more»
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |